Former Congressman Joins FSD Pharma Board

Ontario-based medical cannabis producer FSD Pharma Inc. [stock_market_widget type="inline" template="generic" color="default" assets="HUGE.CN" markup="(CSE: {symbol} {currency_symbol}{price} ({change_pct}))" api="yf"] has appointed former U.S. congressman Stephen Buyer to its board of directors.

Buyer served nine consecutive terms in the House of Representatives between 1993 and 2011. He decided not to seek a tenth term in the House in order to spend more time with his wife, who has incurable autoimmune disease.

Her family has suffered from autoimmune diseases and that inspired Buyer to get involved in the medical cannabis trade. “I am attracted by FSD’s medical research to tame and define the unknown by challenging the edges of medical science to provide relief to people suffering from fibromyalgia and other serious illnesses,” he said.

Buyer had three years of active duty as an officer in the army after graduating from law school. As a captain he spent five months giving legal counsel to commanders and interrogating Iraqi prisoners of war.

His first civilian job saw him become an Indiana state deputy attorney general and he then started his own private law practice. He is a Republican and he was elected to the House of Representatives at 32.

He served on the Committees on Veterans Affairs, Armed Services, Judiciary, Energy and Commerce Committees and also served on the Military Compensation and Retirement Modernization Commission during his time in Congress. He now holds the rank of colonel in the U.S. Army Reserve, and he has also promoted the use of smokeless tobacco on behalf of McKesson Corp.

FSD Pharma has also announced that has approved a consolidation on a 1:201 basis and that it expects to begin trading Class B shares on the CSE this month.

The firm has been through a time of considerable upheaval over the past year, with a number of management changes. Yet it is currently enjoying a period of stability under the leadership of Raza Bokhari.

Its share price was $0.30 at the start of 2019 and it has steadily decreased to $0.05 today, giving it a market cap of $66.4 million.

0 0 votes
Article Rating

The opinions provided in this article are those of the author and do not constitute investment advice. Readers should assume that the author and/or employees of Capital 10X hold positions in the company or companies mentioned in the article. For more information, please see our Content Disclaimer.

Martin Green is an experienced journalist with a strong focus on the cannabis, alcohol, and gambling industries. He is particularly interested in the political issues affecting the global marijuana trade, and he has a keen focus on regulation changes and legal topics. He holds a BA English Literature, MA Creative Writing and a National Qualification in Journalism diploma. He has worked in journalism since 2009 and written for a broad range of newspapers, business titles and magazines, including The Sun, The Metro, The Journal, Livestrong, Drinks Retailing News, Harpers, Sportsbook Review, Vital Football, Essex Live and Surrey Live. Address: 682 Indian Road, Toronto, Ontario, M6P 2C9. Phone: 416-721-8257.
Notify of

Inline Feedbacks
View all comments